Status:

UNKNOWN

Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture

Lead Sponsor:

pninarotman

Collaborating Sponsors:

Meir Medical Center

Conditions:

Hip Fractures

Osteoporotic Fractures

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Due to its prevalence worldwide, osteoporosis is considered a serious public health concern. The worldwide annual incidence of Osteoporotic fractures is approximately 2 million in the US only. Hip fr...

Detailed Description

Study Objectives: * To create a treatment, follow up and rehabilitation protocol for patients who suffered from a hip fracture, in order to prevent a secondary fracture. * To demonstrate that a combi...

Eligibility Criteria

Inclusion

  • Adults over 18 years old
  • Patients diagnosed with low energy osteoporotic hip fracture, and was treated under surgery.

Exclusion

  • Patients not diagnosed with osteoporosis.
  • Patients diagnosed with high energy osteoporotic hip fracture.
  • Patients that suffered from Multiple Trauma.
  • Patients diagnosed with Metabolic diseases or Genetic diseases.
  • Pregnant women

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2016

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT02223572

Start Date

September 1 2014

End Date

May 1 2016

Last Update

August 22 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Meir Medical Center

Kfar Saba, Israel, Israel, 44281